Suppr超能文献

天冬氨酰葡糖胺尿症基因突变携带者与慢性关节炎。

Carriers of the aspartylglucosaminuria genetic mutation and chronic arthritis.

作者信息

Arvio M, Laiho K, Kauppi M, Peippo M, Leino P, Kautiainen H, Kaipiainen-Seppänen O, Mononen I

机构信息

The Pääjärvi Centre, Lammi, Department of Pediatric Neurology, Tampere University Hospital, Finland.

出版信息

Ann Rheum Dis. 2002 Feb;61(2):180-1. doi: 10.1136/ard.61.2.180.

Abstract

OBJECTIVE

To ascertain whether being a carrier of an autosomal recessive disease, aspartylglucosaminuria (AGU), predisposes to chronic arthritis, as does AGU disease.

METHODS

A group of 173 unrelated patients with rheumatoid arthritis (RA) but with no family members with AGU each gave a blood sample for AGUFin major mutation DNA analysis. A group of 131 AGU carriers who were parents of patients with AGU completed a questionnaire on joint symptoms and gave a blood sample for rheumatoid factor (RF) analysis. Eight RF positive parents with prolonged joint symptoms had a rheumatological evaluation.

RESULTS

Six patients (1/28) with RA were carriers of the AGUFin major mutation, whereas the carrier frequency among Finns in general is 1/50 to 1/85. Three AGU carriers had chronic arthritis (2.3%), and 17 (13%) were RF positive; the respective percentages among Finns in general are 1.4% and 5%.

CONCLUSION

As for AGU disease, carrier status may also predispose to chronic arthritis.

摘要

目的

确定作为常染色体隐性疾病——天冬氨酰葡糖胺尿症(AGU)的携带者,是否会像AGU疾病患者那样易患慢性关节炎。

方法

一组173名无AGU家族史的类风湿性关节炎(RA)患者各自提供血样用于AGUFin主要突变DNA分析。一组由131名AGU携带者(均为AGU患者的父母)完成了关于关节症状的问卷调查,并提供血样用于类风湿因子(RF)分析。8名有长期关节症状且RF呈阳性的父母接受了风湿病学评估。

结果

6名(1/28)RA患者是AGUFin主要突变的携带者,而芬兰人群体中的携带者频率一般为1/50至1/85。3名AGU携带者患有慢性关节炎(2.3%),17名(13%)RF呈阳性;芬兰人群体中的相应比例分别为1.4%和5%。

结论

与AGU疾病一样,携带者状态也可能易患慢性关节炎。

相似文献

3
Progressive nature of aspartylglucosaminuria.天冬氨酰葡糖胺尿症的进行性本质。
Acta Paediatr. 2002;91(3):255-7. doi: 10.1080/08035250252833842.
4
Origin of Finnish mutations causing aspartylglucosaminuria.
Hereditas. 1999;131(3):191-5. doi: 10.1111/j.1601-5223.1999.t01-1-00191.x.
7
Dysmorphic facial features in aspartylglucosaminuria patients and carriers.
Clin Dysmorphol. 2004 Jan;13(1):11-5. doi: 10.1097/00019605-200401000-00003.
9
Prospects of carrier screening of aspartylglucosaminuria in Finland.
Eur J Hum Genet. 1993;1(4):296-300. doi: 10.1159/000472427.

引用本文的文献

1
Aspartylglycosaminuria: a review.天冬氨酰氨基葡糖苷尿症:综述
Orphanet J Rare Dis. 2016 Dec 1;11(1):162. doi: 10.1186/s13023-016-0544-6.
3
The Finnish Disease Heritage III: the individual diseases.芬兰疾病遗传谱系III:个体疾病
Hum Genet. 2003 May;112(5-6):470-526. doi: 10.1007/s00439-002-0877-1. Epub 2003 Mar 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验